Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • There is no shortage...

    There is no shortage of coronary stents in the country, claims govt

    Written by savita thakur thakur Published On 2017-03-15T11:08:43+05:30  |  Updated On 15 March 2017 11:08 AM IST
    There is no shortage of coronary stents in the country, claims govt

    NEW DELHI: There is no shortage of coronary stents in the market after substantial reduction of its price and the government is closely monitoring their availability, Lok Sabha was informed.


    "No actionable complaint regarding shortage of Coronary Stents in the market has been received by the government so far," Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said during Question Hour.

    He said the government, through the National Pharmaceuticals Pricing Authority (NPPA), was closely monitoring the situation and has alerted the state governments and state drugs controllers to monitor the availability of the Stents.

    The NPPA notified the ceiling price of Coronary Stent at Rs 7,260 for Bare Metal Stent (BMS) and Rs 29,600 for Drug Eluting Stents (DES), including metallic DES and Bioresorbable Vascular Scaffold (BVS)/Biodegradable Stents.

    The average maximum retail price before the NPPA notification was Rs 45,100 for BMS and Rs 1,21,400 for DES.

    "Price regulation has brought down the prices of Stents - BMS 74 per cent and DES 85 per cent," the Minister said.

    Mandaviya said NPPA has not received any report or references indicating that manufacturers of Stents are trying to create an artificial scarcity of BMS and DES.

    All state governments and state drug controllers have been advised to exercise the power of entry search and seizure as per Drug Price Control Order 2013 if manufacturers or importers or distributors try to create artificial shortage of Stents.

    "NPPA is regularly interacting with the manufacturers/ importers in this regard and stent companies have assured to maintain the required level of availability," he said.
    Bioresorbable Vascular ScaffoldCoronary StentsDrug (Price Control) OrderDrug Eluting StentsMansukh L MandaviyaNational Pharmaceuticals Pricing AuthorityNPPAshortageStents
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok